awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q41386664-F34402C3-EB4C-454D-A1AF-B0931763BF60
Q41386664-F34402C3-EB4C-454D-A1AF-B0931763BF60
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41386664-F34402C3-EB4C-454D-A1AF-B0931763BF60
Natalizumab discontinuation in patients with multiple sclerosis: Profiling risk and benefits at therapeutic crossroads.
P433
Q41386664-F34402C3-EB4C-454D-A1AF-B0931763BF60
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41386664-F34402C3-EB4C-454D-A1AF-B0931763BF60
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
80010b3a2d7be4b4b250900102dbb38e12bd458a
P433
13
http://www.w3.org/2001/XMLSchema#string